Role Of Immature Myeloid Cells in Mechanisms of Immune Evasion In Cancer (original) (raw)

• Almand B, Clark JI, Nikitina E, English NR, Knight SC, Carbone DP and Gabrilovich DI (2001) Increased production of immature myeloid cells in cancer patients A mechanism of immunosuppression in cancer. J Immunol 166:678–689
  PubMed CAS Google Scholar
• Almand B, Resser J, Lindman B, Nadaf S, Clark J, Kwon E, Carbone D and Gabrilovich D (2000) Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6:1755–1766
  PubMed CAS Google Scholar
• Atochina O, Daly-Angel T, Piskorska D and Harn D (2001) A shistosome expressed immunomodulatory glycoconjugate expand peritoneal Gr1+ macrophages that suppress naïve CD4+ T cell proliferation via an interferon-gamma and nitric oxide dependent mechanism. J Immunol 167:4293–4302
  PubMed CAS Google Scholar
• Balkwill F and Mantovani A (2001) Inflammation and cancer:back to Virchow? Lancet 357(9255):539–545
  Article PubMed CAS Google Scholar
• Beck C, Schreiber K, Schreiber H and Rowley D (2001) C-kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serum. Eur J Immunol 33(1):19–28
  Article Google Scholar
• Boucher JL, Moali C and Tenu JP (1999) Nitric oxyde byosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 55:1015–1028
  Article PubMed CAS Google Scholar
• Bromberg J (2002) Stat proteins and oncogenesis. J Clin Invest 109:1139–1142
  Article PubMed CAS Google Scholar
• Bronte V, Apolloni E, Cabrelle A, Ronca R, Serafini P, Zamboni P, Restifo N and Zanovello P (2000) Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 96:3838
  PubMed CAS Google Scholar
• Bronte V, Casic T, Gri G, Gallana K, Borsellino G, Marrigo I, Battistini L, Iafrate M, Prayer-Galletti U, Pagano F and Viola A (2005) Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J Exp Med 201(8):1257–1268
  Article PubMed CAS Google Scholar
• Bronte V, Chappell DB, Apolloni E, Cabrelle A, Wang M, Hwu P and Restifo NP (1999) Unopposed Production of Granulocyte-Macrophage Colony-Stimulating Factor by Tumors Inhibits CD8+ T Cell Responses by Dysregulating Antigen-Presenting Cell Maturation. J Immunol 162: 5728–5737
  PubMed CAS Google Scholar
• Bronte V, Serafini P, Appoloni E and Zanovello P (2001) Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J Immunoth 24:431–446
  Article CAS Google Scholar
• Bronte V, Serafini P, De Santo C, Marigo I, Tosello V, Mazzoni A, Segal DM, Staib C, Lowel M, Sutter G, Colombo MP and Zanovello P (2003) IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J Immunol 170(1):270–278
  PubMed CAS Google Scholar
• Bronte V, Wang M, Overwijk W, Surman D, Pericle F, Rosenberg SA and Restifo NP (1998) Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J Immunol 161:5313–5320
  PubMed CAS Google Scholar
• Cauley L, Miller E, Yen M and Swain S (2000) Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma. J Immunol 165:6056
  PubMed CAS Google Scholar
• Cheng F, Wang HW, Cuenca A, Huang M, Ghansah T, Brayer J, Kerr WG, Takeda K, Akira S, Schoenberger SP, Yu H, Jove R and Sotomayor EM (2003) A critical role for Stat3 signaling in immune tolerance. Immunity 19:425–436
  Article PubMed CAS Google Scholar
• De Santo C, Serafini P, Marigo I, Dolcetti L, Bolla M, P DS, Melani C, Guiducci C, Colombo M, Iezzi M, Musiani P, Zanovello P and Bronte V (2005) Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc Natl Acad Sci U S A 102(11):4185–4190
  Google Scholar
• Gabrilovich D (2004) The mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4:941–952
  Article PubMed CAS Google Scholar
• Gabrilovich D, Cheng P, Fan Y, Yu B, Nikitina E, Sirotkin A, Shurin M, Oyama T, Adachi Y, Nadaf S, Carbone DP and Skoultchi A (2002) H1o Histone and Differentiation of Dendritic Cells A Molecular Target for Tumor-Derived Factors. J Leuk Biol 72:285–296
  CAS Google Scholar
• Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S and Carbone DP (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92(11):4150–4166
  PubMed CAS Google Scholar
• Gabrilovich DI, Velders M, Sotomayor E and Kast WM (2001) Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol 166:5398–5406
  PubMed CAS Google Scholar
• Hengesbach L and Hoag K (2004) Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice. J Nutr 134(10): 2653–2659
  PubMed CAS Google Scholar
• Hestdal K, Ruscetti F, Ihle J, Jacobsen S, Dubois C, Kopp W, Longo D and Keller J (1991) Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 147(1):22–28
  PubMed CAS Google Scholar
• Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R and Gabrilovich DI (2003) All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res 63:4441–4449
  PubMed CAS Google Scholar
• Kusmartsev S and Gabrilovich D (2005) STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J Immunol 174(8): 4880–4891
  PubMed CAS Google Scholar
• Kusmartsev S and Gabrilovich DI (2003) Inhibition of myeloid cell differentiation in cancer:The role of reactive oxygen species. J Leukoc Biol 74(2):186–196
  Article PubMed CAS Google Scholar
• Kusmartsev S, Li Y and Chen S-H (2000) Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol 165:779–785
  PubMed CAS Google Scholar
• Kusmartsev S, Nefedova Y, Yoder D and Gabrilovich DI (2004) Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 172(2):989–999
  PubMed CAS Google Scholar
• Kuwata T, Wang I, Tamura T, Ponnamperuma R, Levine R, Holmes K, Morse H, De Luca L and Ozato K (2000) Vitamin A deficiency in mice causes a systemic expansion of myeloid cells. Blood 95(11):3349–3356
  PubMed CAS Google Scholar
• Lathers D, Clark J, Achille N and Young M (2004) Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. Cancer Immunol Immunother 53(5):422–430
  Article PubMed CAS Google Scholar
• Li Q, Pan PY, Gu P, Xu D and Chen SH (2004) Role of immature myeloid Gr-1+ cells in the development of antitumor immunity. Cancer Res 64(3):1130–1139
  Article PubMed CAS Google Scholar
• Liu Y, Van Ginderachter J, Brys L, De Baetselier P, Raes G and Geldhof A (2003) Nitric oxide-independent CTL suppression during tumor progression:association with arginase-producing (M2) myeloid cells. J Immunol 170(10):5064–5074
  PubMed CAS Google Scholar
• Mantovani A, Sozzani S, Locati M, Allavena P and Sica A (2002) Macrophage polarization:tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549–555
  Article PubMed CAS Google Scholar
• Melani C, Chiodoni C, Forni G and Colombo MP (2003) Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102(6):2138–2145
  Article PubMed CAS Google Scholar
• Mencacci A, Montagnoli C, Bacci A, Cenci E, Pitzurra L, Spreca A, Kopf M, Sharpe A and Romani L (2002) CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J Immunol 169(6):3180–3190
  PubMed CAS Google Scholar
• Menetrier-Caux C, Thomachot MC, Alberti L, Montmain G and Blay JY (2001) IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells. Cancer Res 61(7):3096–3104
  PubMed CAS Google Scholar
• Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R and Gabrilovich D (2004) Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J Immunol 172(1):464–474
  PubMed CAS Google Scholar
• Ostrand-Rosenberg S, Clements VK, Terabe M, Park JM, Berzofsky JA and Dissanayake SK (2002) Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent. J Immunol 169(10):5796–5804
  PubMed CAS Google Scholar
• Otsuji M, Kimura Y, Aoe T, Okamoto Y and Saito T (1996) Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci USA 93:13119–13124
  Article PubMed CAS Google Scholar
• Pandit R, Lathers D, Beal N, Garrity T and Young M (2000) CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer. Ann Otol Rhinol Laryngol 109:749–754
  PubMed CAS Google Scholar
• Pelaez B, Campillo J, Lopez-Asenjo J and Subiza J (2001) Cyclophosphamide induces the development of early myeloid cells suppressing tumor growth by a nitric oxide-dependent mechanism. J Immunol 166:6608
  PubMed CAS Google Scholar
• Pollard J (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71–78
  Article PubMed CAS Google Scholar
• Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, Delgado A, Correa , Brayer J, Sotomayor EM, Antonia S, Ochoa JB and Ochoa AC (2004) Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 64(16):5839–5849
  Article PubMed CAS Google Scholar
• Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB and Ochoa AC (2002) Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem 277:21123–21129
  Article PubMed CAS Google Scholar
• Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, Ochoa JB and Ochoa AC (2003) L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol 171(3):1232–1239
  PubMed CAS Google Scholar
• Saio M, Radoja S, Marino M and Frey AB (2001) Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J Immunol 167(10):5583–5593
  PubMed CAS Google Scholar
• Salvadori S, Martinelli G and Zier K (2000) Resection of solid tumors reverses T cell defects and restores protective immunity. J Immunol 164:2214
  PubMed CAS Google Scholar
• Sauer H, Wartenberg M and Hescheler J (2001) Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11:173–186
  Article PubMed CAS Google Scholar
• Schmielau J and Finn OJ (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 61:4756–4760
  PubMed CAS Google Scholar
• Schreck R, Albermann K and Baeuerle PA (1992) Nuclear factor kappa B:an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17:221–237
  Article PubMed CAS Google Scholar
• Seung L, Rowley D, Dubeym P and Schreiber H (1995) Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection. Proc Natl Acad Sci U S A 92(14):6254–6258
  Article PubMed CAS Google Scholar
• Shankaran V, Ikeda H, Bruce A, White J, Swanson P, Old L and Schreiber R (2001) IFN-gamma and lymphocytes prevent primary tumor development and shape tumor immunogenicity. Nature 410:1107–1111
  Article PubMed CAS Google Scholar
• Sinha P, Clements V and Ostrand-Rosenberg S (2005) Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J Immunol 174(2):636–645
  PubMed CAS Google Scholar
• Subiza J, Vinuela J, Rodriguez R and De la Concha E (1989) Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice. Int J Cancer 44:307–314
  Article PubMed CAS Google Scholar
• Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE and Berzofsky JA (2003) Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med 198(11):1741–1752
  Article PubMed CAS Google Scholar
• Walkley C, Yuan Y, Chandraratna R and McArthur G (2002) Retinoic acid receptor antagonism in vivo expands the numbers of precursor cells during granulopoiesis. Leukemia 16(9):1763–1772
  Article PubMed CAS Google Scholar
• Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, Dalton W, Jove R, Pardoll D and Yu H (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10(1):48–54
  Article PubMed Google Scholar
• Wiers K, Lathers D, Wright M and Young M (2000) Vitamin D3 treatment to diminish the levels of immune suppressive CD34+ cells increases the effectiveness of adoptive immunotherapy. J Immunother 23(1):115–124
  Article PubMed CAS Google Scholar
• Wu G and Morris SM (1998) Arginine metabolism:nitric oxide and beyond. Biochem J 336:1–17
  PubMed CAS Google Scholar
• Yang L, DeBusk L, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, Matrisian L, Carbone D and Lin P (2004) Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6(4):409–421
  Article PubMed CAS Google Scholar
• Young M (2004) Tumor skewing of CD34+ progenitor cell differentiation into endothelial cells. Int J Cancer 109(4):516–524
  Article PubMed CAS Google Scholar
• Young M, Ihm J, Lozano Y, Wright M and Prechel M (1995) Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol Immunother 41(1):37–45
  PubMed CAS Google Scholar
• Young MR and Lathers DM (1999) Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. Int J Immunopharmacol 21:241–252
  Article PubMed CAS Google Scholar
• Young MRI, Wright MA, Matthews JP, Malik I and Pandit R (1996) Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor- b and nitric oxide. J Immunol 156:1916–1921
  PubMed CAS Google Scholar
• Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, McDermott D, Quiceno D, Youmans A, O’Neill A, Mier J and Ochoa AC (2005) Arginase-producing myeloid suppressor cells in renal cell carcinoma patients:a mechanism of tumor evasion. Cancer Res 65(8): 3044–3048
  PubMed CAS Google Scholar